Abcentra is a clinic-stage company developing therapeutic antibodies against oxidized LDL
Employees: 1-10
Founded date: 2006
Mentions in press and media 4
| Date | Title | Description |
| 12.06.2024 | Rivia Secures €3 Million Seed Funding to Transform Clinical Trials | Rivia, a Zurich-based startup at the forefront of AI-driven analytics and clinical trial data infrastructure for biotechs, has successfully raised a substantial €3 million in seed funding. This funding round, spearheaded by Speedinvest, mar... |
| 12.06.2024 | Rivia raises €3M to handle data analytics for biotech companies | Swiss bio-analytics startup Rivia has secured a €3M Seed funding round led by Speedinvest. The funds will be used to hire new teams across engineering and client services, and will also advance product development to fully harness the poten... |
| 12.06.2024 | €3M to bring AI analytics and advanced data infrastructure to clinical trials | Founded by seasoned biopharma experts familiar with the industry's pain points, Rivia focuses on creating user-friendly software tailored to the needs of biotech firms. Rivia addresses a significant inefficiency in the industry: current da... |
| 04.08.2021 | Abcentra Announces First Patients Dosed with Orticumab in Clinical Trial Evaluating Blockade of Oxidized LDL in Psoriasis with Elevated Cardiometabolic Risk |